What is the recommended initial dosing regimen for a patient with diabetes who requires twice-daily (2 times a day) insulin dosing, specifically using NPH (Neutral Protamine Hagedorn) insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Twice-Daily NPH Insulin Dosing Regimen

When converting from bedtime-only NPH to a twice-daily regimen, reduce the total dose to 80% of the current bedtime NPH dose, then administer 2/3 of this reduced dose before breakfast and 1/3 before dinner. 1

Initial Dosing for Twice-Daily NPH

For patients starting NPH insulin who require twice-daily dosing:

  • Begin with 10 units per day or 0.1-0.2 units/kg per day as a single bedtime dose, then convert to twice-daily when glycemic targets are not met with bedtime dosing alone 1

  • When splitting to twice-daily, calculate 80% of the current bedtime NPH dose as the new total daily dose 1, 2

  • Distribute this reduced total as 2/3 before breakfast and 1/3 before dinner (not equal doses—this ratio accounts for greater overnight insulin sensitivity and reduces nocturnal hypoglycemia risk) 1, 3

Conversion Example

If a patient is on 30 units of bedtime NPH:

  • New total daily dose = 24 units (80% of 30 units) 2
  • Morning dose = 16 units (2/3 of 24 units) 2
  • Evening dose = 8 units (1/3 of 24 units) 2

Titration Protocol

  • Increase the dose by 2 units every 3 days to reach fasting plasma glucose target without hypoglycemia 1, 3

  • Monitor fasting glucose to assess the evening NPH dose adequacy; monitor pre-dinner glucose to assess morning NPH dose adequacy 2

  • If hypoglycemia occurs without clear cause, reduce the corresponding dose by 10-20% 1, 4, 3

Adding Prandial Coverage

When twice-daily NPH alone is insufficient:

  • Add 4 units of short/rapid-acting insulin to each injection, or 10% of the reduced NPH dose, for prandial coverage 1, 3

  • This creates a self-mixed/split regimen where NPH and rapid-acting insulins can be adjusted separately 1

Critical Pitfalls to Avoid

  • Never convert unit-for-unit from once-daily to twice-daily dosing—always use the 80% reduction to prevent hypoglycemia during transition 2, 3

  • Never give equal morning and evening doses—the 2/3:1/3 ratio is essential for preventing nocturnal hypoglycemia 3

  • Never delay dose adjustments—reassess every 3 days and titrate based on glucose patterns 2

  • Do not give NPH at bedtime when initiating twice-daily dosing—use the before-dinner timing (1/3 dose) instead 1, 3

Special Considerations

  • Prescribe glucagon for emergent hypoglycemia when initiating NPH therapy, as NPH carries higher hypoglycemia risk than long-acting basal analogs 1

  • For patients on continuous tube feeding requiring NPH, consider splitting into twice or three times daily to cover continuous nutritional intake 3

  • Consider switching from NPH to a basal analog if the patient develops frequent hypoglycemia or consistently forgets evening NPH administration 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Conversion from Lantus to NPH

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

NPH Insulin Dosing Schedule

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Steroid-Induced Hyperglycemia with NPH Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.